
Nukkleus Inc. (NASDAQ:DFNS – Free Report) – Research analysts at Zacks Research issued their Q3 2026 earnings estimates for Nukkleus in a research note issued on Monday, September 14th. Zacks Research analyst T. Kerr forecasts that the company will earn ($2.36) per share for the quarter. The consensus estimate for Nukkleus’ current full-year earnings is ($3.90) per share. Zacks Research also issued estimates for Nukkleus’ Q4 2026 earnings at ($1.80) EPS, FY2027 earnings at ($1.70) EPS, FY2028 earnings at $0.46 EPS, FY2029 earnings at $1.13 EPS and FY2030 earnings at $1.84 EPS.
Several other research analysts also recently weighed in on DFNS. Wall Street Zen downgraded shares of Nukkleus from a “sell” rating to a “strong sell” rating in a research note on Saturday, September 5th. Weiss Ratings cut shares of Nukkleus from a “sell (d+)” rating to a “sell (e+)” rating in a research note on Monday, July 20th. Finally, Noble Financial raised shares of Nukkleus to a “strong-buy” rating in a research report on Monday, June 29th. One equities research analyst has rated the stock with a Strong Buy rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy”.
Nukkleus Stock Down 7.2%
Shares of NASDAQ:DFNS opened at $7.68 on Thursday. The company has a quick ratio of 0.11, a current ratio of 0.14 and a debt-to-equity ratio of 0.07. Nukkleus has a 52-week low of $3.70 and a 52-week high of $1,948.75. The stock’s fifty day simple moving average is $20.64 and its 200-day simple moving average is $57.55. The company has a market capitalization of $12.75 million, a P/E ratio of -0.02 and a beta of -5.88.
Nukkleus (NASDAQ:DFNS – Get Free Report) last posted its earnings results on Wednesday, August 19th. The company reported ($173.80) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($3.11) by ($170.69). The company had revenue of $4.00 million during the quarter, compared to analysts’ expectations of $4.50 million.
About Nukkleus
Nukkleus Inc, a financial technology company, provides blockchain-enabled technology solutions worldwide. It focuses on providing software and technology solutions for retail foreign exchange trading industry. The company provides transactions platform for dealing and risk management services. It also offers cross-border payment and transactions solutions and blockchain-enabled financial services solutions to institutional investors. In addition, the company provides software, technology, customer sales and marketing, and risk management technology hardware and software solutions.
Recommended Stories
- Five stocks we like better than Nukkleus
- 3 Luxury Consumer Brands to Watch in a Beaten-Down Sector
- Jackson’s Record Quarter Powers the Bull Case
- Holiday Shopping Is Almost Here—And Target May Be Ready to Win Big
- AI Panic Hit Tech Stocks—But NVIDIA’s Growth Engine Is Intact
Receive News & Ratings for Nukkleus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nukkleus and related companies with MarketBeat.com's FREE daily email newsletter.
